Novo Nordisk A/S
The Senior Global Pricing Lead sets the pricing direction for assets in their therapy area, from early development through launch, turning clinical innovation into a clear pricing rationale. This role provides leadership with insights to make sharper decisions on development, investment, and launch sequence while ensuring pricing reflects treatment value and supports patient access. The position involves global collaboration to align pricing strategies with commercial, access, and clinical goals.
Headquarters
Alle, Central Jutland, Denmark
Company Size
10001+ employees
Founded
1923
Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark, with the stated purpose of driving change to defeat diabetes and other serious chronic diseases. It researches, develops, manufactures and markets pharmaceutical products and medical devices across diabetes care, obesity, haemophilia, growth disorders and other endocrine conditions, and is widely known for its insulin and GLP‑1 therapies. Combining extensive R&D, large‑scale manufacturing and global commercial reach, Novo Nordisk emphasizes patient‑centred care, access programs and sustainability in its work to improve outcomes for people with chronic disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novo Nordisk A/S.
Novo Nordisk A/S didn’t post a salary, so this is our estimate from similar listings.
Director, Global Value, Access & Pricing – NSCLC
Revolution Medicines
Director, Global Value, Access & Pricing – CRC
Revolution Medicines
Director, Global Access Strategy & Pricing, Oncology Pipeline & BD
Pfizer
Associate Director, Global Value, Access, Pricing, and Reimbursement
BeOne Medicines
Director, Global Market Access and Pricing Strategy, Cell Therapy
Bristol Myers Squibb
Associate Director, Global Value, Access, Pricing, and Reimbursement
BeOne Medicines